Table 2. Summary of clinical symptoms in international cohort (n=60,510)

Total Male Female
Rash (all types) 21,472 (83.6%) 20,436 (83.7%) 399 (66.1%)
Fever 14,842 (57.8%) 14,184 (58.1%) 306 (50.7%)
Systemic rash 12,730 (49.6%) 11,769 (48.2%) 327 (54.1%)
Genital rash 11,696 (45.5%) 11,125 (45.6%) 141 (23.3%)
Headache 7,556 (29.4%) 7,069 (29.0%) 244 (40.4%)
Fatigue 7,523 (29.3%) 7,008 (28.7%) 186 (30.8%)
Lymphadenopathy (all types) 7,453 (29.0%) 7,327 (30.0%) 115 (19.0%)
Muscle ache 6,919 (26.9%) 6,475 (26.5%) 211 (34.9%)
General lymphadenopathy 6,235 (24.3%) 6,134 (25.1%) 96 (16.1%)
Local lymphadenopathy 4,779 (18.6%) 4,711 (19.3%) 59 (9.9%)
Rash, unknown location 3,271 (12.7%) 3,250 (13.3%) 19 (3.1%)
Sore throat 3,162 (12.3%) 2,902 (11.9%) 92 (15.2%)
Oral rash 2,502 (9.7%) 2,049 (8.4%) 37 (6.1%)
Chills 1,635 (6.4%) 1,307 (5.4%) 38 (6.3%)
Cough 486 (1.9%) 396 (1.6%) 14 (2.5%)
Vomiting 467 (1.8%) 439 (1.8%) 25 (4.1%)
Asymptomatic 20 (0.1%) 20 (0.1%) 0
Other 3 (0.0%) 2 (0.0%) 1 (0.2%)
Conjunctivitis 0 0 0
Diarrhea 0 0 0
Genital edema 0 0 0
Lymphadenopathy, location unknown 0 0 0
Anogenital pain and/or bleeding 0 0 0